AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
250.94
-6.47 (-2.51%)
At close: Jul 31, 2026, 4:00 PM EDT
251.85
+0.91 (0.36%)
After-hours: Jul 31, 2026, 7:59 PM EDT
AbbVie Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 64,386 | 61,160 | 56,334 | 54,318 | 58,054 | 56,197 |
Revenue Growth | 10.39% | 8.57% | 3.71% | -6.44% | 3.30% | 22.69% |
Gross Profit Gross Profit Growth | 46,021 | 42,956 | 39,430 | 33,903 | 40,640 | 38,751 |
Operating Income Operating Income Growth | 16,870 | 15,075 | 9,137 | 12,757 | 18,117 | 17,924 |
Net Income Net Income Growth | 6,310 | 4,226 | 4,278 | 4,863 | 11,836 | 11,542 |
Earnings Per Share EPS Growth | 3.54 | 2.36 | 2.39 | 2.72 | 6.63 | 6.45 |
EPS Growth | 68.57% | -1.26% | -12.13% | -58.97% | 2.79% | 137.13% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Immunology Immunology Growth | 32,587 | 30,406 | 26,682 | 26,136 | 28,924 | 25,284 |
Neuroscience Neuroscience Growth | 11,905 | 10,767 | 8,999 | 7,717 | 6,528 | 5,927 |
Oncology Oncology Growth | 6,627 | 6,655 | 6,555 | 5,915 | 6,577 | 7,228 |
Aesthetics Aesthetics Growth | 4,947 | 4,860 | 5,176 | 5,294 | 5,333 | 5,233 |
Eye Care Eye Care Growth | - | 2,109 | 2,242 | 2,415 | 2,701 | 3,567 |
Other Key Products Other Key Products Growth | 3,820 | 3,736 | 3,648 | 3,806 | 3,854 | 5,489 |
All Other All Other Growth | 3,411 | 2,627 | 3,032 | 3,035 | 4,137 | 2,673 |
Revenue (Total) Revenue (Total) Growth | 64,386 | 61,160 | 56,334 | 54,318 | 58,054 | 56,197 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 9,391 | 5,257 | 5,555 | 12,816 | 9,229 | 9,830 |
Total Debt Total Debt Growth | 72,858 | 67,496 | 67,144 | 59,385 | 63,271 | 76,684 |
Net Cash (Debt) Net Cash Growth | -63,467 | -62,239 | -61,589 | -46,569 | -54,042 | -66,854 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -35.80 | -35.10 | -34.74 | -26.27 | -30.39 | -37.62 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 21,224 | 19,030 | 18,806 | 22,839 | 24,943 | 22,777 |
Capital Expenditures CapEx Growth | -1,244 | -1,214 | -974 | -777 | -695 | -787 |
Free Cash Flow Free Cash Flow Growth | 19,980 | 17,816 | 17,832 | 22,062 | 24,248 | 21,990 |
Free Cash Flow Growth | 29.87% | -0.09% | -19.17% | -9.01% | 10.27% | 30.97% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.48% | 70.24% | 69.99% | 62.42% | 70.00% | 68.96% |
Operating Margin | 26.20% | 24.65% | 16.22% | 23.49% | 31.21% | 31.89% |
Pretax Margin | 13.51% | 10.79% | 6.60% | 11.51% | 23.21% | 23.11% |
Profit Margin | 9.81% | 6.92% | 7.61% | 8.97% | 20.40% | 20.55% |
FCF Margin | 0.00% | 29.13% | 31.65% | 40.62% | 41.77% | 39.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 6.920 | 6.650 | 6.290 | 5.990 | 5.710 | 5.310 |
Dividend Per Share Growth | 5.56% | 5.72% | 5.01% | 4.90% | 7.53% | 9.71% |
Dividend Yield | 2.76% | 2.88% | 3.51% | 3.85% | 3.51% | 3.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 70.89 | 96.82 | 74.35 | 56.97 | 24.38 | 20.99 |
Forward PE | 16.46 | 16.57 | 14.81 | 13.96 | 12.72 | 10.04 |
P/FCF Ratio | 22.19 | 22.67 | 17.59 | 12.40 | 11.79 | 10.89 |
PS Ratio | 6.89 | 6.61 | 5.57 | 5.04 | 4.93 | 4.26 |